Pregnancy outcomes in women with pulmonary hypertension: a retrospective study in China

Abstract Background In recent years, with the development of monitoring conditions and the application of pulmonary vascular-targeted drugs, pregnancy outcomes in women with pulmonary hypertension (PH) have improved, but the maternal mortality rate is still high. The purpose of this study was to des...

Full description

Bibliographic Details
Main Authors: Chengtian Lv, Yuwen Huang, Guangyuan Liao, Lichan Wu, Dunjin Chen, Yuanmei Gao
Format: Article
Language:English
Published: BMC 2023-01-01
Series:BMC Pregnancy and Childbirth
Subjects:
Online Access:https://doi.org/10.1186/s12884-023-05353-7
_version_ 1828063525804703744
author Chengtian Lv
Yuwen Huang
Guangyuan Liao
Lichan Wu
Dunjin Chen
Yuanmei Gao
author_facet Chengtian Lv
Yuwen Huang
Guangyuan Liao
Lichan Wu
Dunjin Chen
Yuanmei Gao
author_sort Chengtian Lv
collection DOAJ
description Abstract Background In recent years, with the development of monitoring conditions and the application of pulmonary vascular-targeted drugs, pregnancy outcomes in women with pulmonary hypertension (PH) have improved, but the maternal mortality rate is still high. The purpose of this study was to describe the maternal-foetal outcomes in pregnant women with PH. Methods The clinical data of 154 pregnant women with PH who were admitted to the Third Affiliated Hospital of Guangzhou Medical University from January 2011 to December 2020 were collected and descriptively analysed. Results Among the 154 pregnant women with PH, 6 (3.9%) had idiopathic pulmonary arterial hypertension (iPAH), 41 (26.6%) had pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD-PAH), 45 (29.2%) had PAH related to other diseases (oPAH), and 62 (40.3%) had PH related to left heart disease (LHD-PH). The systolic pulmonary artery pressure (sPAP) was 36–49 mmHg in 53.2% of the patients, 50–69 mmHg in 22.1% of the patients and ≥ 70 mmHg in 24.7% of the patients. Five (3.2%) pregnant women died within 1 week after delivery; iPAH patients had the highest mortality rate (3/6, 50%). Fifty-four patients (35.1%) were admitted to the intensive care unit (ICU), and the incidence of heart failure during pregnancy was 14.9%. A total of 70.1% of the patients underwent caesarean section; 42.9% had premature infants; 28.6% had low-birth-weight (LBW) infants; 13.0% had very-low-birth-weight (VLBW) infants; 3.2% had extremely-low-birth-weight (ELBW) infants; 61% had small for gestational age (SGA) infants; and 1.9% experienced neonatal mortality. Conclusion There were significant differences in the maternal-foetal outcomes in the iPAH, CHD-PAH, oPAH and LHD-PH groups. Maternal mortality was highest in the iPAH group; therefore, iPAH patients should be advised to prevent pregnancy. Standardized and multidiscipline-assisted maternal management is the key to improving maternal-foetal outcomes.
first_indexed 2024-04-10T22:44:51Z
format Article
id doaj.art-6763c5579009484ba38dabc8b0e9ec3c
institution Directory Open Access Journal
issn 1471-2393
language English
last_indexed 2024-04-10T22:44:51Z
publishDate 2023-01-01
publisher BMC
record_format Article
series BMC Pregnancy and Childbirth
spelling doaj.art-6763c5579009484ba38dabc8b0e9ec3c2023-01-15T12:23:55ZengBMCBMC Pregnancy and Childbirth1471-23932023-01-012311910.1186/s12884-023-05353-7Pregnancy outcomes in women with pulmonary hypertension: a retrospective study in ChinaChengtian Lv0Yuwen Huang1Guangyuan Liao2Lichan Wu3Dunjin Chen4Yuanmei Gao5Department of Critical Care Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, The Third Affiliated Hospital of Guangzhou Medical UniversityDepartment of Critical Care Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, The Third Affiliated Hospital of Guangzhou Medical UniversityDepartment of Critical Care Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, The Third Affiliated Hospital of Guangzhou Medical UniversityDepartment of Critical Care Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, The Third Affiliated Hospital of Guangzhou Medical UniversityDepartment of Obstetrics and Gynecology, Department of Fetal Medicine and Prenatal Diagnosis, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, The Third Affiliated Hospital of Guangzhou Medical UniversityDepartment of Critical Care Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, The Third Affiliated Hospital of Guangzhou Medical UniversityAbstract Background In recent years, with the development of monitoring conditions and the application of pulmonary vascular-targeted drugs, pregnancy outcomes in women with pulmonary hypertension (PH) have improved, but the maternal mortality rate is still high. The purpose of this study was to describe the maternal-foetal outcomes in pregnant women with PH. Methods The clinical data of 154 pregnant women with PH who were admitted to the Third Affiliated Hospital of Guangzhou Medical University from January 2011 to December 2020 were collected and descriptively analysed. Results Among the 154 pregnant women with PH, 6 (3.9%) had idiopathic pulmonary arterial hypertension (iPAH), 41 (26.6%) had pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD-PAH), 45 (29.2%) had PAH related to other diseases (oPAH), and 62 (40.3%) had PH related to left heart disease (LHD-PH). The systolic pulmonary artery pressure (sPAP) was 36–49 mmHg in 53.2% of the patients, 50–69 mmHg in 22.1% of the patients and ≥ 70 mmHg in 24.7% of the patients. Five (3.2%) pregnant women died within 1 week after delivery; iPAH patients had the highest mortality rate (3/6, 50%). Fifty-four patients (35.1%) were admitted to the intensive care unit (ICU), and the incidence of heart failure during pregnancy was 14.9%. A total of 70.1% of the patients underwent caesarean section; 42.9% had premature infants; 28.6% had low-birth-weight (LBW) infants; 13.0% had very-low-birth-weight (VLBW) infants; 3.2% had extremely-low-birth-weight (ELBW) infants; 61% had small for gestational age (SGA) infants; and 1.9% experienced neonatal mortality. Conclusion There were significant differences in the maternal-foetal outcomes in the iPAH, CHD-PAH, oPAH and LHD-PH groups. Maternal mortality was highest in the iPAH group; therefore, iPAH patients should be advised to prevent pregnancy. Standardized and multidiscipline-assisted maternal management is the key to improving maternal-foetal outcomes.https://doi.org/10.1186/s12884-023-05353-7PregnancyPulmonary hypertensionMaternal-foetal outcome
spellingShingle Chengtian Lv
Yuwen Huang
Guangyuan Liao
Lichan Wu
Dunjin Chen
Yuanmei Gao
Pregnancy outcomes in women with pulmonary hypertension: a retrospective study in China
BMC Pregnancy and Childbirth
Pregnancy
Pulmonary hypertension
Maternal-foetal outcome
title Pregnancy outcomes in women with pulmonary hypertension: a retrospective study in China
title_full Pregnancy outcomes in women with pulmonary hypertension: a retrospective study in China
title_fullStr Pregnancy outcomes in women with pulmonary hypertension: a retrospective study in China
title_full_unstemmed Pregnancy outcomes in women with pulmonary hypertension: a retrospective study in China
title_short Pregnancy outcomes in women with pulmonary hypertension: a retrospective study in China
title_sort pregnancy outcomes in women with pulmonary hypertension a retrospective study in china
topic Pregnancy
Pulmonary hypertension
Maternal-foetal outcome
url https://doi.org/10.1186/s12884-023-05353-7
work_keys_str_mv AT chengtianlv pregnancyoutcomesinwomenwithpulmonaryhypertensionaretrospectivestudyinchina
AT yuwenhuang pregnancyoutcomesinwomenwithpulmonaryhypertensionaretrospectivestudyinchina
AT guangyuanliao pregnancyoutcomesinwomenwithpulmonaryhypertensionaretrospectivestudyinchina
AT lichanwu pregnancyoutcomesinwomenwithpulmonaryhypertensionaretrospectivestudyinchina
AT dunjinchen pregnancyoutcomesinwomenwithpulmonaryhypertensionaretrospectivestudyinchina
AT yuanmeigao pregnancyoutcomesinwomenwithpulmonaryhypertensionaretrospectivestudyinchina